Discovery of N-(1,3,4-thiadiazol-2-yl)benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR/HER-2 dual-target inhibitors against cancer growth and angiogenesis-Reference-Cited by-同舟云学术

Discovery of N-(1,3,4-thiadiazol-2-yl)benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR/HER-2 dual-target inhibitors against cancer growth and angiogenesis

Published:2022-02 Issue: Volume:119 Page:105469
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Li Xin-yang,Wang De-pu,Li Shuai,Xue Wen-han,Qian Xin-hua,Liu Kai-li,Li Yu-heng,Lin Qi-qi,Dong Gang,Meng Fan-hao,Jian Ling-yan

Funder

National Natural Science Foundation of China

Shengjing Hospital

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference30 articles.

1. The impact of oral contraceptive use on breast cancer risk: State of the art and future perspectives in the era of 4P medicine;Bonfiglio;Semin. Cancer Biol.,2021

2. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets;Liang;Semin. Cancer Biol.,2020

3. Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression;Márquez-Garbán;Cancer Lett.,2019

4. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency;Lane;Mol. Cell. Biol.,2000

5. The choice of systemic adjuvant therapy in receptor-positive early breast cancer;Dellapasqua;Eur. J. Cancer.,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of novel quinazoline-derived EGFR/HER-2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agents;Bioorganic Chemistry;2024-10

2. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10

3. Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer;Medicinal Research Reviews;2024-05-20

4. Synthesis and antiproliferative potency of 1,3,4-thiadiazole and 1,3-thiazolidine-4-one based new binary heterocyclic molecules: in vitro cell-based anticancer studies;RSC Medicinal Chemistry;2024

5. Synthesis of 1,3,4-Thiadiazole Derivatives and Their Anticancer Evaluation;International Journal of Molecular Sciences;2023-12-14